UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Studies leading to the identification of ZD1839 (Iressa) : An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

Bioorganic & medicinal chemistry letters, 2001-07, Vol.11 (14), p.1911-1914

2001

Volltextzugriff (PDF)

ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy

Cancer research (Chicago, Ill.), 2002-10, Vol.62 (20), p.5749-5754

2002

Volltextzugriff (PDF)

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives

Journal of medicinal chemistry, 1992-03, Vol.35 (5), p.877-885

1992

Volltextzugriff (PDF)

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP Potassium Channel Openers. Modifications on the Western Region

Journal of medicinal chemistry, 1997-03, Vol.40 (6), p.1048-1048

1997

Volltextzugriff (PDF)

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives

Journal of medicinal chemistry, 1992-03, Vol.35 (5), p.877

1992

Volltextzugriff (PDF)

Biosynthesis of porphyrins and related macrocycles. Part 14. Studies with [14C]isoporphobilinogen and four isomeric labelled pyrromethanes: specific conversion of the unrearranged pyrromethane NH3.AP.AP into haem and protoporphyrin-IX

Journal of the Chemical Society, Perkin Transactions 1, 1981, p.2771

1981

Volltextzugriff (PDF)

Biosynthesis of porphyrins and related macrocycles. Part I. Synthesis of 14C-labelled pyrromethanes

Journal of the Chemical Society, Perkin Transactions 1, 1973, p.1546

1973

Volltextzugriff (PDF)

Intermediates in porphyrin biosynthesis: studies with 14C- and 13C-labelled pyrromethanes

Journal of the Chemical Society. Chemical communications, 1973 (20), p.768

1973

Volltextzugriff (PDF)

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP Potassium Channel Openers. Modifications on the Western Region

Journal of medicinal chemistry, 1996-11, Vol.39 (23), p.4592-4601

1996

Volltextzugriff (PDF)

ChemInform Abstract: Studies Leading to the Identification of ZD1839 (Iressa): An Orally Active, Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Targeted to the Treatment of Cancer

ChemInform, 2001-11, Vol.32 (46), p.no-no

2001

Volltextzugriff (PDF)

CHAPTER 2 - Biosynthesis and metabolism of prostaglandins and thromboxanes

Prostaglandins and Thromboxanes, 1982, p.8-18

Gibson, Keith H.

1982

Volltextzugriff (PDF)

Identification of novel hydroxy fatty acids in the barnacle Balanus balanoides

Biochimica et biophysica acta, 1990-12, Vol.1047 (3), p.239-246

1990

Volltextzugriff (PDF)

Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells

PloS one, 2016-12, Vol.11 (12), p.e0167442-e0167442

2016

Volltextzugriff (PDF)

ChemInform Abstract: BIOSYNTHESIS OF PORPHYRINS AND RELATED MACROCYCLES PART 1, SYNTHESIS OF (14)C‐LABELLED PYRROMETHANES

Chemischer Informationsdienst, 1973-10, Vol.4 (44)

1973

Volltextzugriff (PDF)

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

The New England journal of medicine, 2012-01, Vol.366 (1), p.9-19

2012

Volltextzugriff (PDF)

Usefulness of Neutrophil/Lymphocyte Ratio As Predictor of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting

The American journal of cardiology, 2010-01, Vol.105 (2), p.186-191

2010

Volltextzugriff (PDF)

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

The New England journal of medicine, 2017-05, Vol.376 (20), p.1933-1942

2017

Volltextzugriff (PDF)

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

The New England journal of medicine, 2016-12, Vol.375 (25), p.2423-2434

2016

Volltextzugriff (PDF)

Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting

The American heart journal, 2007-11, Vol.154 (5), p.995-1002

2007

Volltextzugriff (PDF)

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3360-3368

2013

Volltextzugriff (PDF)

Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery

Circulation (New York, N.Y.), 2006-10, Vol.114 (14), p.1468-1475

2006

Volltextzugriff (PDF)

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Journal of clinical oncology, 2010-06, Vol.28 (16), p.2674-2681

2010

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(144)
Reviews
(13)
Buchkapitel
(2)

Sprache

Englisch
(159)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Studies leading to the identification of ZD1839 (Iressa) : An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP Potassium Channel Openers. Modifications on the Western Region

New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives

N -Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: K ATP Potassium Channel Openers. Modifications on the Western Region

Biosynthesis of porphyrins and related macrocycles. Part 14. Studies with [14C]isoporphobilinogen and four isomeric labelled pyrromethanes: specific conversion of the unrearranged pyrromethane NH3.AP.AP into haem and protoporphyrin-IX

Biosynthesis of porphyrins and related macrocycles. Part I. Synthesis of 14C-labelled pyrromethanes

Intermediates in porphyrin biosynthesis: studies with 14C- and 13C-labelled pyrromethanes

N -Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: K ATP Potassium Channel Openers. Modifications on the Western Region

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP Potassium Channel Openers. Modifications on the Western Region

ChemInform Abstract: Studies Leading to the Identification of ZD1839 (Iressa): An Orally Active, Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Targeted to the Treatment of Cancer

CHAPTER 2 - Biosynthesis and metabolism of prostaglandins and thromboxanes

Identification of novel hydroxy fatty acids in the barnacle Balanus balanoides

Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells

ChemInform Abstract: BIOSYNTHESIS OF PORPHYRINS AND RELATED MACROCYCLES PART 1, SYNTHESIS OF (14)C‐LABELLED PYRROMETHANES

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

Usefulness of Neutrophil/Lymphocyte Ratio As Predictor of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Suchergebnisse filtern